National Peroxide Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Net Income	110.37	-22.46	167.9
Depreciation & Amortization	207.9	200.68	190.49
Other Amortization	-	0.4	2.11
Loss (Gain) From Sale of Assets	0.04	11.7	-2.13
Loss (Gain) From Sale of Investments	-18.94	-24.26	-25.43
Provision & Write-off of Bad Debts	1.21	0.76	-
Other Operating Activities	55.26	-29.14	-12.48
Change in Accounts Receivable	-29	42.58	-28.1
Change in Inventory	-55.87	13.61	23.77
Change in Accounts Payable	-33.87	-15.56	2.34
Change in Unearned Revenue	-	-13.84	28.95
Change in Other Net Operating Assets	105.29	22.21	16.61
Operating Cash Flow	342.4	186.68	364.04
Operating Cash Flow Growth	83.42%	-48.72%	-
Capital Expenditures	-44.49	-48.9	-146.34
Sale of Property, Plant & Equipment	0.06	6.54	2.25
Investment in Securities	-195.1	18.73	-36.17
Other Investing Activities	10.13	6.37	5.14
Investing Cash Flow	-229.4	-17.27	-175.12
Long-Term Debt Repaid	-40.02	-37.69	-39.51
Net Debt Issued (Repaid)	-40.02	-37.69	-39.51
Common Dividends Paid	-	-71.84	-100.57
Other Financing Activities	-13.55	-15.91	-27.08
Financing Cash Flow	-53.57	-125.44	-167.16
Foreign Exchange Rate Adjustments	-0.68	-0.78	0.06
Net Cash Flow	58.75	43.19	21.81
Free Cash Flow	297.91	137.78	217.7
Free Cash Flow Growth	116.23%	-36.71%	-
Free Cash Flow Margin	10.28%	4.80%	6.54%
Free Cash Flow Per Share	51.83	23.97	37.88
Cash Interest Paid	13.55	15.91	26.78
Cash Income Tax Paid	-13.87	28.52	74.05
Levered Free Cash Flow	327.3	38.66	-
Unlevered Free Cash Flow	335.77	49.07	-
Change in Working Capital	-13.45	49	43.58